Phase 3
Prostate Cancer Clinical Trial
Recruiting
Recruiting
Recruiting
Recruiting
Estimated trial completion date
Nov 1, 2026
INNOVATE Trial
The INNOVATE Trial is for patients with node-positive prostate cancer with an elevated PSA post-prostatectomy.
It investigates whether adding apalutamide to standard radiation and hormone therapy improves outcomes.